This legislation aims to combat the international drug trade, particularly focusing on the production and distribution of illegal synthetic narcotics linked to the People's Republic of China. By authorizing the U.S. government to impose sanctions on individuals and entities involved in these activities, the bill seeks to address the opioid crisis and related public health issues in the United States. Key provisions grant the President the authority to impose sanctions on foreign individuals or entities that contribute to the proliferation of illicit synthetic narcotics.